ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 10.58
+0.10 (0.95%)
Feb 4, 2026, 2:55 PM CST
SHA:600479 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 250.04 | 230.76 | 320.41 | 302.51 | 302.06 | 297.07 |
Depreciation & Amortization | 97.92 | 97.92 | 103.65 | 95.6 | 85.93 | 60.89 |
Other Amortization | 22.63 | 22.63 | 18.53 | 16.8 | 16.22 | 15.89 |
Loss (Gain) From Sale of Assets | -0.5 | -0.5 | - | - | -33.54 | -5.1 |
Asset Writedown & Restructuring Costs | 4.69 | 4.69 | 0.94 | -0.17 | 0.43 | -0.22 |
Loss (Gain) From Sale of Investments | -16.22 | -16.22 | -15.87 | -19.65 | -26.41 | -24.96 |
Provision & Write-off of Bad Debts | 5.61 | 5.61 | 17.84 | 2.17 | -0.29 | 2.74 |
Other Operating Activities | 253.42 | 78.83 | 79.28 | 88.17 | 75.41 | 66.58 |
Change in Accounts Receivable | 18.73 | 18.73 | -8.69 | -163.72 | 275.85 | 27.18 |
Change in Inventory | 44.61 | 44.61 | 62.29 | -51.22 | -52.4 | -27.26 |
Change in Accounts Payable | -147.8 | -147.8 | -132.49 | 465.43 | -160.39 | 128.17 |
Change in Other Net Operating Assets | 60.88 | 60.88 | - | - | - | - |
Operating Cash Flow | 592.64 | 398.77 | 443.12 | 733.47 | 485.57 | 542.37 |
Operating Cash Flow Growth | 41.72% | -10.01% | -39.59% | 51.05% | -10.47% | 248.81% |
Capital Expenditures | -73.67 | -47.32 | -43.99 | -34.43 | -71.88 | -97.24 |
Sale of Property, Plant & Equipment | 0.6 | 0.39 | 0.06 | 0.2 | 30.82 | 6.41 |
Investment in Securities | -1,501 | -700 | 618.4 | 130.07 | -25.18 | -893.6 |
Other Investing Activities | 1.51 | 5.75 | 10.82 | 26.32 | 22.9 | 22.88 |
Investing Cash Flow | -1,572 | -741.18 | 585.29 | 122.15 | -43.34 | -961.55 |
Long-Term Debt Issued | - | - | 42.15 | - | 60 | 132.49 |
Long-Term Debt Repaid | - | -69.41 | -74.6 | -43.83 | -149.85 | -19.12 |
Net Debt Issued (Repaid) | -38.46 | -69.41 | -32.46 | -43.83 | -89.85 | 113.37 |
Issuance of Common Stock | - | - | 0.44 | 48.59 | - | - |
Repurchase of Common Stock | -16.54 | -16.54 | -3.38 | - | - | - |
Common Dividends Paid | -147.85 | -152.82 | -147.89 | -248.65 | -429.53 | -209.34 |
Other Financing Activities | 9.15 | -11.36 | -18.72 | -20.29 | -1.2 | -8.27 |
Financing Cash Flow | -193.7 | -250.12 | -202 | -264.19 | -520.58 | -104.24 |
Net Cash Flow | -1,173 | -592.54 | 826.4 | 591.43 | -78.35 | -523.41 |
Free Cash Flow | 518.97 | 351.45 | 399.13 | 699.04 | 413.69 | 445.14 |
Free Cash Flow Growth | 37.15% | -11.95% | -42.90% | 68.97% | -7.06% | 287.48% |
Free Cash Flow Margin | 14.28% | 9.68% | 10.51% | 17.36% | 11.29% | 12.27% |
Free Cash Flow Per Share | 1.27 | 0.85 | 0.94 | 1.63 | 0.99 | 1.06 |
Cash Income Tax Paid | 322.37 | 347.79 | 329.57 | 290.93 | 319.05 | 298.78 |
Levered Free Cash Flow | 488.37 | 226.34 | 241.45 | 716.2 | 333.96 | 228.92 |
Unlevered Free Cash Flow | 488.48 | 227.04 | 242.5 | 717.59 | 335.28 | 230.32 |
Change in Working Capital | -24.94 | -24.94 | -81.67 | 248.05 | 65.76 | 129.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.